Work Productivity Improvement Associated With Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients With Psoriatic Arthritis Results of a Phase 3, Randomized, Controlled Trial

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.2572
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Longterm (52-Week) Results of a Phase III Randomized, Controlled Trial of Apremilast in Patients With Psoriatic Arthritis

Journal of Rheumatology
RheumatologyAllergyImmunology
2015English

Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative Colitis

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2020English

Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis

Rheumatology and Therapy
2014English

Improved Patient-Reported Outcomes in Patients With Psoriatic Arthritis Treated With Abatacept: Results From a Phase 3 Trial

Arthritis Research & Therapy
2018English

A Phase 2 Randomized Trial of Apremilast in Patients With Atopic Dermatitis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

PMS62 Improved Fatigue and Physical Function Are Correlated With Health-Related Quality of Life in Psoriatic Arthritis Subjects Treated With Apremilast: Results From a Phase 2, Randomized, Controlled Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

SAT0436 Durability of Apremilast Response in Patients With Psoriatic Arthritis: Long-Term (208-Week) Results From the Palace 1 Trial

2017English

A Case of Pityriasis Rubra Pilaris Treated Successfully With the Phosphodiesterase-4 Inhibitor Apremilast

Acta Dermato-Venereologica
DermatologyMedicine
2018English

Pss13 - Budget Impact Analysis of Apremilast in Patients With Active Psoriatic Arthritis in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy